Of relevance are studies linking AHR genetic polymorphisms to tobacco-smoke–induced decreases in birth weight (Sasaki et al. 2006), along with associated microalbuminuria, proteinuria, and heightened risk of end-stage renal disease (Zandi-Nejad et al. 2006). This evidence concerns the gene AHR and stage 5 chronic kidney disease.